Meinhard, M; Koenig, LC; Pelc, A et al.
TRANSCRIPTION-DEPENDENT AND TRANSCRIPTION-INDEPENDENT REGULATION OF MCL-1 BY THE P53 FAMILYHEPATOLOGY. Bd. 54. 2011 S. 790A-790A
Lutz, J; Sollinger, D; Schmaderer, C et al.
TREATMENT WITH THE CALCIUM SENSING RECEPTOR AGONIST R-568 DOES NOT PROTECT FROM RENAL ISCHEMIA/REPERFUSION INJURYTRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 32-32
Sulkowski, MS; Asselah, T; Ferenci, P et al.
TREATMENT WITH THE SECOND GENERATION HCV PROTEASE INHIBITOR BI201 335 RESULTS IN HIGH AND CONSISTENT SVR RATES - RESULTS FROM SILEN-C1 IN TREATMENT-NAiVE PATIENTS ACROSS DIFFERENT BASELINE FACTORSHEPATOLOGY. Bd. 54. 2011 S. 473A-473A
Schimanski, CC; Schlaegel, F; Jordan, M et al.
VEGF-D Correlates with Metastatic Disease in Gastric Cancer Patients Undergoing SurgeryWORLD JOURNAL OF SURGERY. Bd. 35. H. 5. 2011 S. 1010-1016
Waldner, MJ; Wirtz, SJ; Jefremow, A et al.
VEGFR2 Signaling in Intestinal Epithelial Cells Drives Development of Colitis-Associated Colon CancerGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S351-S351
Zeuzem, S; Soriano, V; Asselah, T et al.
VIROLOGIC RESPONSE TO AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, WITH AND WITHOUT RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: WEEK 12 INTERIM RESULTS OF THE SOUND-C2 STUDYHEPATOLOGY. Bd. 54. 2011 S. 1436A-1436A
Mudter, J
What's new about inflammatory bowel diseases in 2011WORLD JOURNAL OF GASTROENTEROLOGY. Bd. 17. H. 27. 2011 S. 3177-3177
Moussata, D; Berger, F; Chauvenet, M et al.
Yield of Neoplasia by Confocal Laser Endomicroscopy in the Chronic Atrophic GastritisGASTROENTEROLOGY. Bd. 140. H. 5. 2011 S. S748-S749
Larrey, D; Lohse, A; de Ledinghen, V et al.
4 WEEK THERAPY WITH THE NON-NUCLEOSIDIC POLYMERASE INHIBITOR BI207127 IN COMBINATION WITH PEGINTERFERON-ALFA2A AND RIBAVIRIN IN TREATMENT NAIVE AND TREATMENT EXPERIENCED CHRONIC HCV GT1 PATIENTSJOURNAL OF HEPATOLOGY. Bd. 52. 2010 S. S466-S466
Reinel, H; Schassburger, K; Meyer, D et al.
5-Fluorouracil, Leucovorin and Oxaliplatin (FOLFOX4) as postoperative adjuvant chemotherapy (CT) for patients with node positive rectal cancer after radiochemotherapy (R-CT) and surgeryONKOLOGIE. Bd. 33. 2010 S. 173-173